Edition:
United States

Integra LifeSciences Holdings Corp (IART.OQ)

IART.OQ on NASDAQ Stock Exchange Global Select Market

49.65USD
4:00pm EDT
Change (% chg)

$0.88 (+1.80%)
Prev Close
$48.77
Open
$48.90
Day's High
$50.05
Day's Low
$48.77
Volume
290,293
Avg. Vol
219,753
52-wk High
$50.05
52-wk Low
$36.22

Latest Key Developments (Source: Significant Developments)

Integra LifeSciences Q1 adjusted earnings per share $0.39
Wednesday, 26 Apr 2017 06:00am EDT 

April 26 (Reuters) - Integra LifeSciences Holdings Corp ::Integra LifeSciences reports first quarter 2017 financial results.Q1 adjusted earnings per share $0.39.Q1 GAAP earnings per share $0.08.Q1 revenue $258.6 million versus I/B/E/S view $253.9 million.Q1 earnings per share view $0.40 -- Thomson Reuters I/B/E/S.Sees FY 2017 revenue $1.12 billion to $1.14 billion.Maintaining previously issued 2017 full-year sales, organic growth, EPS and cash flow guidance.Fy2017 earnings per share view $1.91, revenue view $1.13 billion -- Thomson Reuters I/B/E/S.  Full Article

Integra Lifesciences says court dismissed stockholder class action lawsuit
Thursday, 20 Apr 2017 08:01am EDT 

April 20 (Reuters) - Integra Lifesciences Holdings Corp :Says court dismissed stockholder class action lawsuit in relation to derm deal; Integra to pay plaintiffs' counsel $225,000.  Full Article

Integra Lifesciences announces commercial expansion of Cadence Total Ankle System
Tuesday, 28 Mar 2017 08:30am EDT 

Integra Lifesciences Holdings Corp : Integra Lifesciences announces commercial expansion of Cadence Total Ankle System .Integra Lifesciences Holdings - plans to initiate several global post-market clinical studies with Cadence System to further support product efficacy.  Full Article

Integra LifeSciences Q4 adjusted earnings per share $0.52
Thursday, 23 Feb 2017 07:00am EST 

Integra LifeSciences Holdings Corp : Integra LifeSciences reports fourth quarter and full-year 2016 financial results and updates 2017 full-year guidance . Sees FY 2017 adjusted earnings per share $1.88 to $1.94 . Sees FY 2017 GAAP earnings per share $0.49 to $0.55 . Q4 adjusted earnings per share $0.52 . Q4 GAAP earnings per share $0.35 . Q4 revenue $255.7 million versus I/B/E/S view $257.3 million . Sees FY 2017 revenue $1.12 billion to $1.14 billion . Q4 earnings per share view $0.52 -- Thomson Reuters I/B/E/S .Fy2017 earnings per share view $1.93, revenue view $1.10 billion -- Thomson Reuters I/B/E/S.  Full Article

Integra Lifesciences to buy Derma Sciences
Tuesday, 10 Jan 2017 08:00pm EST 

Derma Sciences Inc : Derma Sciences to be acquired by Integra Lifesciences for $7.00 per share of common stock in cash . Says will be acquired by Integra Lifesciences Holdings Corporation for $7.00 per share of common stock in cash . Says deal for a total of approximately $204 million . Says Integra will also assume contingent liabilities related to biod transaction . Says q4 net sales of $26.9 million .Says q4 awc net sales of $20.3 million representing growth of 95.6%.  Full Article

Integra lifesciences sees FY 2017 adj shr $1.91 to $1.97
Tuesday, 10 Jan 2017 08:00pm EST 

Integra Lifesciences Holdings Corp : Integra Lifesciences Holdings - expects Q4 2016 gaap and adjusted diluted EPS to be at or above mid-point of prior guidance range of $0.32 to $0.35 and $0.50 to $0.53 respectively . Integra Lifesciences to acquire Derma Sciences Inc. and announces preliminary fourth quarter and full year 2016 financial results and 2017 outlook . Sees FY 2017 adjusted earnings per share $1.91 to $1.97 . Sees FY 2017 revenue about $1.05 billion to $1.07 billion . Sees Q4 2016 revenue about $256 million . Sees FY 2016 revenue about $992 million . Integra Lifesciences- expects deal to add about $65 million in revenue and to be dilutive to adjusted earnings per share by about three cents during 2017 . "Preliminary 2017 guidance does not include acquisition of Derma Sciences, Inc., which has not closed" . Says expects 7% to 8.5% organic revenue growth in 2017 .Derma Sciences acquisition is expected to turn accretive to adjusted earnings in 2018.  Full Article

Integra Lifesciences Holdings files for potential mixed shelf offering - SEC filing
Friday, 4 Nov 2016 08:17am EDT 

Integra Lifesciences Holdings Corp :Files for potential mixed shelf offering; size not disclosed - SEC filing.  Full Article

Integra Lifesciences sees 2016 sales $992 mln-$1.002 bln
Thursday, 28 Jul 2016 06:00am EDT 

Integra Lifesciences Holdings Corp : Raising its FY gaap and adjusted eps guidance by $0.04/share and narrowing guidance range to new range of $1.78 - $1.88 and $3.43 - $3.53, respectively . Integra lifesciences reports second quarter 2016 financial results . Q2 adjusted earnings per share $0.79 . Q2 gaap earnings per share $0.32 . Q2 revenue $249.3 million versus i/b/e/s view $243.2 million . Sees fy 2016 sales $992 million to $1.002 billion . Q2 earnings per share view $0.76 -- Thomson Reuters I/B/E/S . Integra lifesciences holdings corp says q2 gaap gross margin was 64.1% and adjusted gross margin was 69.2% . Integra lifesciences holdings corp says raising organic sales guidance to 9%. For 2016 .FY2016 earnings per share view $3.44, revenue view $994.8 million -- Thomson Reuters I/B/E/S.  Full Article

Integra Lifesciences Holdings Corp raises low end of prior guidance range
Wednesday, 27 Apr 2016 06:01am EDT 

Integra Lifesciences Holdings Corp:Raising low end of FY 2016 revenue guidance to a new range of $985 million to $1.0 billion, up from prior guidance of $975 million to $1.0 billion.Raises Fy 2016 organic revenue growth to about 8% from its previous guidance of about 7%.Adjusts low end of its FY 2016 adjusted earnings per share guidance range to $3.38 - $3.50 from $3.35 - $3.50.Says the company's GAAP EPS guidance is now $1.73 to $1.85.  Full Article

Integra LifeSciences Holdings Corp announces Service Alliance Agreement With PREZIO Health
Thursday, 25 Feb 2016 04:30pm EST 

Integra LifeSciences Holdings Corp:Integra Lifesciences announces service alliance agreement with prezio health.Says prezio health will act as integra's authorized surgical instruments service provider.  Full Article

More From Around the Web